Pharmathen
44, Kifissias Avenue, 151 25
Maroussi
Athens
151 25
Tel: 30 210 66 04 300
Fax: 30 210 66 66 749
Website: http://www.pharmathen.com/
Email: info@pharmathen.com
About Pharmathen
Pharmathen is a research-oriented company aiming at the development of high quality pharmaceutical products both in the field of generics and innovative finished formulations. Pharmathen invests more than €20 million annually in Research and Development, developing 10-12 new generic molecules per year. In addition Pharmathen develops 3-4 projects of innovative formulations every year concerning mainly the development of advanced pharmaceutical and drug delivery technologies as well as their application in selected drug substances. With the application of innovative techniques and advanced technologies, Pharmathen aims to provide challenging solutions LCM of brand companies as well as to develop and establish new technology platforms and provide optimized pharmaceutical products to patients.
YEAR FOUNDED:
1969
LEADERSHIP:
CFO: Panagiotis Georgalas
JOBS:
Please click here for Pharmathen job opportunities.
PRODUCTS:
All Products
FOLLOW PHARMATHEN:
Tweets by Pharmathen
3 articles about Pharmathen
-
CASI Pharmaceuticals Enters Exclusive China Distribution License Agreement For Octreotide Long Acting Injectable (LAI) Microsphere For Neuroendocrine Cancers And Acromegaly
11/7/2019
CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces an exclusive distribution agreement with Pharmathen Global BV for the development and distribution of octreotide long acting injectable microsphere in China.
-
Quit Smoking Without Nicotine: Pharmathen Hellas S.A. to Distribute Acetium Lozenge in Greece
1/30/2018
The first deliveries of the product will be in early 2018.
-
Upsher-Smith Laboratories Enters Into Exclusive Development And Distribution Agreement With Pharmathen
9/27/2016